The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
We’re invested in health to develop the next generation of medical innovations.
Venture capitalMelbourne, Australiabrandoncapital.vcSince 2025-02-03
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer. | Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $112M | 2025-02-03 | [ PART ] |